Advertisement

The Kidney Transplant Biopsy

  • Jose R. Torrealba
  • Milagros D. Samaniego
Chapter

Abstract

The kidney transplant biopsy is an important tool for the diagnosis of kidney transplant dysfunction, and with advances in clinical kidney transplantation, biopsies are increasingly being used to help guide therapy and therapy choice.

Keywords

Delay Graft Function Kidney Allograft Protocol Biopsy Peritubular Capillary Transplant Glomerulopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF et al. . International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411.CrossRefPubMedGoogle Scholar
  2. 2.
    Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y et al. . The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713.CrossRefPubMedGoogle Scholar
  3. 3.
    Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753.CrossRefPubMedGoogle Scholar
  4. 4.
    Remuzzi G, Grinyo J, Ruggenenti P, Beatini M, Cole EH, Milford EL, Brenner BM. Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol 1999;10:2591.PubMedGoogle Scholar
  5. 5.
    Anglicheau D, Loupy A, Lefaucheur C, Pessione F, Letourneau I, Cote I, Gaha K, Noel LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 2008;8:2325.CrossRefPubMedGoogle Scholar
  6. 6.
    Woestenburg AT, Verpooten GA, Ysebaert DK, Van Marck EA, Verbeelen D, Bosmans JL. Fibrous intimal thickening at implantation adversely affects long-term kidney allograft function. Transplantation 2009;87:72.CrossRefPubMedGoogle Scholar
  7. 7.
    Mancilla E, Avila-Casado C, Uribe-Uribe N, Morales-Buenrostro LE, Rodriguez F, Vilatoba M, Gabilondo B, Aburto S, Rodriguez RM, Magana S, Magana F, Alberu J. Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities. Transplantation 2008;86:1684.CrossRefPubMedGoogle Scholar
  8. 8.
    Waltzer WC, Miller F, Arnold A, Jao S, Anaise D, Rapaport FT. Value of percutaneous core needle biopsy in the differential diagnosis of renal transplant dysfunction. J Urol 1987;137:1117.PubMedGoogle Scholar
  9. 9.
    Al-Awwa IA, Hariharan S, First MR. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis. Am J Kidney Dis 1998;31:S15.PubMedGoogle Scholar
  10. 10.
    Matas AJ, Tellis VA, Sablay L, Quinn T, Soberman R, Veith FJ. The value of needle renal allograft biopsy. III. A prospective study. Surgery 1985;98:922.PubMedGoogle Scholar
  11. 11.
    Colvin RB, Cohen AH, Saiontz C, Bonsib S, Buick M, Burke B, Carter S, Cavallo T, Haas M, Lindblad A, Manivel JC, Nast CC, Salomon D, Weaver C, Weiss M. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997;8:1930.PubMedGoogle Scholar
  12. 12.
    Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 1995;60:1215.PubMedGoogle Scholar
  13. 13.
    Torrealba JR, Katayama M, Fechner JH Jr., Jankowska-Gan E, Kusaka S, Xu Q, Schultz JM, Oberley TD, Hu H, Hamawy MM, Jonker M, Wubben J, Doxiadis G, Bontrop R, Burlingham WJ, Knechtle SJ. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol 2004;172:5753.PubMedGoogle Scholar
  14. 14.
    Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roenneburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, VanBuskirk AM, Torrealba JR, Burlingham WJ. Human CD4+CD25 low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol 2007;178:3983.PubMedGoogle Scholar
  15. 15.
    Torrealba J, Burlingham W. Transforming Growth factor Beta and the immunopathologic assessment of tolerance. Curr Opin Organ Transplant 2004;9:241.CrossRefGoogle Scholar
  16. 16.
    Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002;13:779.PubMedGoogle Scholar
  17. 17.
    Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001;12:574.PubMedGoogle Scholar
  18. 18.
    Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, Cosimi AB, Colvin RB. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999;10:2208.PubMedGoogle Scholar
  19. 19.
    Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003;3:708.CrossRefPubMedGoogle Scholar
  20. 20.
    Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007;18:1046.CrossRefPubMedGoogle Scholar
  21. 21.
    Colvin RRenal transplant pathology. In Heptinstall’s Pathology of the Kidney. Jennette JC, Olson JL, Schwartz MM, Silva FG, (eds.), 6th Ed., Vol. II. Lippincott-Raven, Philadelphia, p. 1347, 2006.Google Scholar
  22. 22.
    Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005;68:1866.CrossRefPubMedGoogle Scholar
  23. 23.
    Lorenz M, Regele H, Schillinger M, Exner M, Rasoul-Rockenschaub S, Wahrmann M, Kletzmayr J, Silberhumer G, Horl WH, Bohmig GA. Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation 2004;78:447.CrossRefPubMedGoogle Scholar
  24. 24.
    Haas M, Rahman MH, Racusen LC, Kraus ES, Bagnasco SM, Segev DL, Simpkins CE, Warren DS, King KE, Zachary AA, Montgomery RA. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006;6:1829.CrossRefPubMedGoogle Scholar
  25. 25.
    Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal O, Mollnes TE. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003;75:1204.CrossRefPubMedGoogle Scholar
  26. 26.
    Kuypers DR, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003;76:102.CrossRefPubMedGoogle Scholar
  27. 27.
    Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ. Banff ‘05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’). Am J Transplant 2007;7:518.CrossRefPubMedGoogle Scholar
  28. 28.
    Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003;75:1034.CrossRefPubMedGoogle Scholar
  29. 29.
    Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005;16:2804.CrossRefPubMedGoogle Scholar
  30. 30.
    Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 2005;80:1194.CrossRefPubMedGoogle Scholar
  31. 31.
    Torrealba J, Lopez F, Djamali A, Knechtle S, Sollinger S, Pirsch J, Samaniego M. Histopathologic parameters of acute allograft rejection in kidney biopsies associated with the development of chronic allograft injury. Am Soc Transplant 2008;8:1. Am J Transplan.CrossRefGoogle Scholar
  32. 32.
    Regele H, Bohmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002;13:2371.CrossRefPubMedGoogle Scholar
  33. 33.
    Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004;4:124.CrossRefPubMedGoogle Scholar
  34. 34.
    Sijpkens YW, Joosten SA, Wong MC, Dekker FW, Benediktsson H, Bajema IM, Bruijn JA, Paul LC. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004;65:2409.CrossRefPubMedGoogle Scholar
  35. 35.
    Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, DeGoey SR, Lager DJ, Grande JP, Stegall MD. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006;6:1841.CrossRefPubMedGoogle Scholar
  36. 36.
    Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004;4:1033.CrossRefPubMedGoogle Scholar
  37. 37.
    Fidler ME, Gloor JM, Lager DJ, Larson TS, Griffin MD, Textor SC, Schwab TR, Prieto M, Nyberg SL, Ishitani MB, Grande JP, Kay PA, Stegall MD. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004;4:101.CrossRefPubMedGoogle Scholar
  38. 38.
    Mengel M, Bogers J, Bosmans JL, Seron D, Moreso F, Carrera M, Gwinner W, Schwarz A, De Broe M, Kreipe H, Haller H. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005;5:1050.CrossRefPubMedGoogle Scholar
  39. 39.
    Dickenmann M, Steiger J, Descoeudres B, Mihatsch M, Nickeleit V. The fate of C4d positive kidney allografts lacking histological signs of acute rejection. Clin Nephrol 2006;65:173.PubMedGoogle Scholar
  40. 40.
    D’Agati VD. Morphologic features of cyclosporine nephrotoxicity. Contrib Nephrol 1995;114:84.PubMedGoogle Scholar
  41. 41.
    Mihatsch MJ, Thiel G, Ryffel B. Morphologic diagnosis of cyclosporine nephrotoxicity. Semin Diagn Pathol 1988;5:104.PubMedGoogle Scholar
  42. 42.
    Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988;20:759.PubMedGoogle Scholar
  43. 43.
    Sis B, Dadras F, Khoshjou F, Cockfield S, Mihatsch MJ, Solez K. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006;6:1444.CrossRefPubMedGoogle Scholar
  44. 44.
    Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K. Primary acute renal failure (“acute tubular necrosis”) in the transplanted kidney: morphology and pathogenesis. Medicine (Baltimore) 1989;68:173.CrossRefGoogle Scholar
  45. 45.
    Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 1996;61:1331.CrossRefPubMedGoogle Scholar
  46. 46.
    Renkens JJ, Rouflart MM, Christiaans MH, van den Berg-Loonen EM, van Hooff JP, van Heurn LW. Outcome of nonheart-beating donor kidneys with prolonged delayed graft function after transplantation. Am J Transplant 2005;5:2704.CrossRefPubMedGoogle Scholar
  47. 47.
    Rudich SM, Kaplan B, Magee JC, Arenas JD, Punch JD, Kayler LK, Merion RM, Meier-Kriesche HU. Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002;74:1715.CrossRefPubMedGoogle Scholar
  48. 48.
    Jain S, Curwood V, White SA, Furness PN, Nicholson ML. Sub-clinical acute rejection detected using protocol biopsies in patients with delayed graft function. Transpl Int 2000; 13(Suppl 1):S52.CrossRefPubMedGoogle Scholar
  49. 49.
    Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004;364:1814.CrossRefPubMedGoogle Scholar
  50. 50.
    Vivette DD’A, Jennette JC, Silva FG. 2005. Pathology of Renal Transplantation. In Atlas of Nontumor Pathology. Non-Neoplastic Kidney Disease. AFIP:667.Google Scholar
  51. 51.
    Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz C, Roza AM, Vincenti F, George V. Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry. Transplant Proc 1999;31:223.CrossRefPubMedGoogle Scholar
  52. 52.
    Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 2006;69:504.CrossRefPubMedGoogle Scholar
  53. 53.
    Hebert D, Kim EM, Sibley RK, Mauer MS. Post-transplantation outcome of patients with hemolytic-uremic syndrome: update. Pediatr Nephrol 1991;5:162.CrossRefPubMedGoogle Scholar
  54. 54.
    Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis 2003;42:1058.CrossRefPubMedGoogle Scholar
  55. 55.
    Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 2001;60:1948.CrossRefPubMedGoogle Scholar
  56. 56.
    Ponticelli C, Traversi L, Banfi G. Renal transplantation in patients with IgA mesangial glomerulonephritis. Pediatr Transplant 2004;8:334.CrossRefPubMedGoogle Scholar
  57. 57.
    Antignac C, Hinglais N, Gubler MC, Gagnadoux MF, Broyer M, Habib R. De novo membranous glomerulonephritis in renal allografts in children. Clin Nephrol 1988;30:1.PubMedGoogle Scholar
  58. 58.
    Monga G, Mazzucco G, Basolo B, Quaranta S, Motta M, Segoloni G, Amoroso A. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1993;6:249.PubMedGoogle Scholar
  59. 59.
    Gobel J, Olbricht CJ, Offner G, Helmchen U, Repp H, Koch KM, Frei U. Kidney transplantation in Alport’s syndrome: long-term outcome and allograft anti-GBM nephritis. Clin Nephrol 1992;38:299.PubMedGoogle Scholar
  60. 60.
    Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006;6:2006.CrossRefPubMedGoogle Scholar
  61. 61.
    Mengel M, Chapman JR, Cosio FG, Cavaille-Coll MW, Haller H, Halloran PF, Kirk AD, Mihatsch MJ, Nankivell BJ, Racusen LC, Roberts IS, Rush DN, Schwarz A, Seron D, Stegall MD, Colvin RB. Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant 2007;7:512.CrossRefPubMedGoogle Scholar
  62. 62.
    Colvin RB. Eye of the needle. Am J Transplant 2007;7:267.CrossRefPubMedGoogle Scholar
  63. 63.
    Karpinski J, Lajoie G, Cattran D, Fenton S, Zaltzman J, Cardella C, Cole E. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999;67:1162.CrossRefPubMedGoogle Scholar
  64. 64.
    Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004;78:242.CrossRefPubMedGoogle Scholar
  65. 65.
    Kee TY, Chapman JR, O’Connell PJ, Fung CL, Allen RD, Kable K, Vitalone MJ, Nankivell BJ. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006;82:36.CrossRefPubMedGoogle Scholar
  66. 66.
    Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005;5:2464.CrossRefPubMedGoogle Scholar
  67. 67.
    Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007;7:576.CrossRefPubMedGoogle Scholar
  68. 68.
    Hoffmann SC, Hale DA, Kleiner DE, Mannon RB, Kampen RL, Jacobson LM, Cendales LC, Swanson SJ, Becker BN, Kirk AD. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005;5:573.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag US 2010

Authors and Affiliations

  1. 1.Pathology and Laboratory MedicineUniversity of Wisconsin Hospital and ClinicsMadisonUSA
  2. 2.Departments of Medicine and SurgeryUniversity of Wisconsin Hospital and ClinicsMadisonUSA

Personalised recommendations